Your browser doesn't support javascript.
loading
Short Communication: Lived experience perspectives on genetic testing for a rare eye disease.
Tam, Mallorie T; Daboub, Alonso; Lou, Hayami; Robillard, Julie M.
Afiliação
  • Tam MT; Department of Medicine, Division of Neurology, University of British Columbia, Vancouver, BC, Canada.
  • Daboub A; BC Children's and Women's Hospital, Vancouver, BC, Canada.
  • Lou H; Department of Medicine, Division of Neurology, University of British Columbia, Vancouver, BC, Canada.
  • Robillard JM; BC Children's and Women's Hospital, Vancouver, BC, Canada.
J Community Genet ; 15(1): 97-101, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37787878
ABSTRACT
This qualitative study explored the motivators and barriers for genetic testing for individuals with aniridia. Semi-structured interviews were conducted with 8 participants. The main findings highlighted the complex and interrelated factors involved in the decision-making process, including family planning, learning about the specific pathogenic variant of the disease and having access to genetic testing. Benefits and potential risks of genetic testing for aniridia were also discussed. For participants, gaining knowledge about their condition was perceived as a benefit, while administrative issues and concerns around privacy were identified as risks. Increased access to quality information about genetic testing and to the service and associated resources are needed to better support people living with aniridia.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article